© 2016 by Cannatol

NEED ASSISTANCE?


info@Cannatol.com

BE OUR FRIEND

STAY CONNECTED

  • Facebook Clean
Please reload

Recent Posts

   DENVER, CO, March 05, 2019 -- JC Pharma Inc. (Boulder, CO) was recently awarded a US Patent (US10206901B2) entitled, "Method and composition for ac...

First Cannabinoid-Based Rapid Seizure Cessation Formulation Patent Granted to Colorado Startup

March 5, 2019

1/1
Please reload

Featured Posts

First Cannabinoid-Based Rapid Seizure Cessation Formulation Patent Granted to Colorado Startup

March 5, 2019

   DENVER, CO, March 05, 2019 -- JC Pharma Inc. (Boulder, CO) was recently awarded a US Patent (US10206901B2) entitled, "Method and composition for acute treatment of seizures" for its Cannabis sativa-derived intranasal formulation used to terminate ongoing seizure activity in epilepsy and self-injurious behavior in autistic children. With this patent and the Cannatol product line JC is following in the footsteps of GW Pharmaceuticals (NASDAQ:GWPH) and their pioneering FDA approved cannabis-derived drug, Epidiolex. 

 

(Click Link for Full Story)

Share on Facebook
Share on Twitter
Please reload

Follow Us

I'm busy working on my blog posts. Watch this space!

Please reload

Search By Tags
Please reload

Archive
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square